Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
Masakazu Toi(Kyoto University), Shigemitsu Takashima(Shikoku Cancer Center)
Cited by 94
Related Papers
Prognostic significance of tumor/stromal caveolin‐1 expression in breast cancer patients
|Cancer Science|2011|62
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
|Breast Cancer Research and Treatment|2013|55
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
|Frontiers in Oncology|2017|29